Hyoscyamus niger (botany)

Alkaloid Profile

Hyoscyamus niger contains the same class of tropane alkaloids as Datura and Mandragora:

Hyoscyamine (L-atropine) is typically the dominant alkaloid. It is the more potent, naturally occurring levorotatory isomer of atropine, with approximately twice the anticholinergic potency of the racemic mixture. Hyoscyamine acts as a competitive antagonist at all muscarinic receptor subtypes (M1–M5), blocking the normal action of acetylcholine at both central (CNS) and peripheral (autonomic) targets.

Scopolamine (hyoscine) is present in significant amounts and is primarily responsible for the amnestic and sedative-deliriant central effects. Scopolamine crosses the blood-brain barrier more readily than atropine and produces the characteristic anticholinergic delirium and amnesia.

Atropine (racemic hyoscyamine) is formed from racemization of hyoscyamine during extraction and processing, and is present in variable amounts.

Tropine and other minor alkaloids are present in smaller concentrations.

Alkaloid Distribution in Plant

Alkaloid content varies by plant part: seeds and roots typically have the highest concentrations, leaves and flowers intermediate, and stems the lowest. Total alkaloid content in the dried plant ranges from 0.06–0.17% in leaves to 0.2–0.5% in seeds. This variability, while somewhat lower than Datura, still makes dose calibration from plant material unreliable and dangerous.

Mechanism

The anticholinergic mechanism is identical to that described for Datura: muscarinic receptor blockade throughout the CNS and autonomic nervous system, producing the full anticholinergic toxidrome. The ratio of scopolamine to hyoscyamine in Henbane tends to produce a somewhat more sedative profile compared to Datura, consistent with historical reports of its use as a sleep-inducing agent.

Ancient Mediterranean and Near Eastern Use

Hyoscyamus niger has one of the longest and most extensively documented histories of any psychoactive plant in Western civilization. Its use is attested from ancient Mesopotamia, Egypt, Greece, and Rome, and it remained a cornerstone of European pharmacy from classical antiquity through the 19th century, when its active alkaloids were isolated and replaced by pure compounds.

The ancient Sumerians (circa 3000–1000 BCE) are believed to have used Henbane — a plant called shakirshiku in cuneiform records has been tentatively identified as Henbane and described as a dental analgesic. Ancient Egyptian medical papyri reference a plant whose description matches Henbane. Greek physicians — Dioscorides, Pliny the Elder, and Galen — documented Henbane extensively. Dioscorides' De Materia Medica (circa 60 CE), the foundational text of Western pharmacy for over 1,500 years, described four varieties of Henbane and their medical uses: to induce sleep, treat pain, manage eye disorders (topical scopolamine dilates pupils — an effect exploited by Renaissance Italian women to appear more attractive, giving Atropa belladonna its name: "beautiful woman"), and as a surgical sedative.

Role in Ancient Oracle Traditions

A highly significant historical hypothesis, supported by growing archaeological and chemical evidence, proposes that Henbane played a central role in the Oracle at Delphi — the most famous and politically influential religious institution of the ancient Greek world. The Delphic oracle (Pythia) delivered prophecies in an altered state of consciousness attributed in ancient sources to vapors rising from a chasm in the earth.

Geological investigation of the sanctuary at Delphi confirmed that naturally occurring gaseous emissions (including ethylene) emerge from fissures in the rock. But ethylene alone may not account for the depth of prophetic trance described. Archaeobotanist John Scarborough and classical pharmacologist Retief and Cilliers have argued that Henbane, along with other psychoactive plants available in the sanctuary's gardens, may have been burned and inhaled — or consumed in other preparations — as part of the Pythia's ritual preparation. While this hypothesis remains debated among classicists, the evidence for psychoactive plant use at Delphi is stronger than once recognized.

Witchcraft and the Witches' Brew

Henbane is one of the canonical ingredients of the "flying ointment" and "witches' brew" described in European witch trial records from the 15th–17th centuries. Together with Datura stramonium, Atropa belladonna, and Mandragora officinarum, Henbane-based preparations are the most plausible pharmacological explanation for the consistently reported phenomena of witchcraft: flight, attendance at nocturnal sabbaths, sexual encounters with supernatural beings, and prophecy.

The physician Johannes Weyer (1563) and later Giambattista della Porta (1588) both described the composition of these ointments and their effects — della Porta claimed to have personally observed witches applying such preparations and falling into deep sleep during which they reported flight and supernatural encounters. Modern pharmacological analysis confirms that the alkaloids in these preparations (applied topically, possibly in fat-based vehicles that enhanced transdermal absorption) would produce exactly the described phenomena: vivid, highly mobile hallucinations experienced as physically real.

Medieval and Renaissance Pharmacy

Throughout the medieval period, Henbane was central to Western pharmacy — one of the key analgesic and soporific agents in the physician's repertoire. "Dwale" — a medieval surgical anesthetic combining Henbane, Mandragora, and opium — was used for pain management during surgical procedures. The reliability and safety of dwale depended entirely on the preparation knowledge of individual herbalists, and fatal overdoses were not uncommon.

Henbane's role in medieval pharmaceutical culture is documented in manuscripts from Benedictine monasteries, herbals including the Cologne Herbarius (1484), and academic medical texts. It was cultivated in monastery gardens alongside other medicinal plants.

19th Century Chemistry and Medical Legacy

The isolation of hyoscyamine from Henbane by German chemists Geiger and Hesse in 1833, and of scopolamine shortly thereafter, transformed the pharmacological landscape. These pure compounds — more reliable and dosaable than raw plant extracts — found widespread medical use as preanesthetic sedatives, motion sickness treatments (scopolamine transdermal patches remain in use today), and ophthalmological mydriatics. The legacy of Henbane in modern medicine continues in the clinical use of scopolamine, atropine, and related compounds derived from or modeled on the plant's alkaloids.